12 results
10-K
2018 FY
GOSS
Gossamer Bio Inc
22 Mar 19
Annual report
4:45pm
, suspend or limit approvals of such product;
we may be required to recall a product or change the way such product is administered to patients … development or to recall batches of our product candidates; and
in the event of approval to market and commercialize our product candidates, an inability
DRS
nml6 q0clel6314zn
11 Oct 18
Draft registration statement
12:00am
424B4
v7mbjkun7s6xz7ek4gp
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1
bo2ri8aj9kw 68hka2hh
21 Dec 18
IPO registration
4:39pm
8-K
EX-10.1
zgfwnbrnkzv8fln4
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
S-1/A
d0752oy7h9p683vbhst
23 Jan 19
IPO registration (amended)
4:39pm
DRS/A
79o51qgeslmymw7zn68t
29 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next